International Journal of Cancer Management

Published by: Kowsar

Axillary Recurrence Rate in Patients with Breast Cancer and Negative Sentinel Lymph Node Biopsy

Samaneh Sajjadi 1 , Hossein Rahimi 1 , Ali Alamdaran 1 , Mohammad Naser Forghani 1 , Ramin Sadeghi 1 and Abbas Abdollahi 1 , *
Authors Information
1 Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • International Journal of Cancer Management: August 2018, 11 (8); e8330
  • Published Online: December 31, 2017
  • Article Type: Research Article
  • Received: July 18, 2016
  • Revised: October 31, 2016
  • Accepted: December 16, 2017
  • DOI: 10.5812/ijcm.8330

To Cite: Sajjadi S, Rahimi H, Alamdaran A, Forghani M N, Sadeghi R, et al. Axillary Recurrence Rate in Patients with Breast Cancer and Negative Sentinel Lymph Node Biopsy, Int J Cancer Manag. 2018 ; 11(8):e8330. doi: 10.5812/ijcm.8330.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Lyman GH, Giuliano AE, Somerfield MR, Benson A3, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23(30):7703-20. doi: 10.1200/JCO.2005.08.001. [PubMed: 16157938].
  • 2. Del Bianco P, Zavagno G, Burelli P, Scalco G, Barutta L, Carraro P, et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol. 2008;34(5):508-13. doi: 10.1016/j.ejso.2007.05.017. [PubMed: 17614245].
  • 3. Schlichting E, Harr ME, Sauer T, Babovic A, Karesen R. [Sentinel lymph node biopsy in breast cancer]. Tidsskr Nor Laegeforen. 2006;126(16):2098-100. [PubMed: 16932777].
  • 4. Brunicardi C, Anderson D, Billiar T, Dunn G, Hunter J, Matthews J. Shuartz principal of surgery. 10 ed. USA: McGraw Hill; 2010.
  • 5. Schwartz GF, Krill LS, Palazzo JP, Dasgupta A. Value of intraoperative examination of axillary sentinel nodes in carcinoma of the breast. J Am Coll Surg. 2008;207(5):758-62. doi: 10.1016/j.jamcollsurg.2008.06.341. [PubMed: 18954790].
  • 6. Montgomery LL, Thorne AC, Van Zee KJ, Fey J, Heerdt AS, Gemignani M, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg. 2002;95(2):385-8. [PubMed: 12145056].
  • 7. Koukouraki S, Sanidas E, Askoxilakis J, Stathaki M, Charalambakis V, Daboudi M, et al. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla? Nucl Med Commun. 2009;30(1):48-53. doi: 10.1097/MNM.0b013e3283139302. [PubMed: 19020472].
  • 8. Schrenk P, Hatzl-Griesenhofer M, Shamiyeh A, Waynad W. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol. 2001;77(3):165-70. [PubMed: 11455552].
  • 9. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15(6):2345-50. doi: 10.1200/JCO.1997.15.6.2345. [PubMed: 9196149].
  • 10. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349(9069):1864-7. doi: 10.1016/S0140-6736(97)01004-0. [PubMed: 9217757].
  • 11. O'Hea BJ, Hill AD, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg. 1998;186(4):423-7. [PubMed: 9544956].
  • 12. Nano MT, Kollias J, Farshid G, Gill PG, Bochner M. Clinical impact of false-negative sentinel node biopsy in primary breast cancer. Br J Surg. 2002;89(11):1430-4. doi: 10.1046/j.1365-2168.2002.02233.x. [PubMed: 12390387].
  • 13. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer--a multicenter validation study. N Engl J Med. 1998;339(14):941-6. doi: 10.1056/NEJM199810013391401. [PubMed: 9753708].
  • 14. Chua B, Olivotto IA, Donald JC, Hayashi AH, Doris PJ, Turner LJ, et al. Outcomes of sentinel node biopsy for breast cancer in British Columbia, 1996 to 2001. Am J Surg. 2003;185(2):118-26. [PubMed: 12559440].
  • 15. Bergkvist L, Frisell J, Liljegren G, Celebioglu F, Damm S, Thorn M. Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer. Br J Surg. 2001;88(12):1644-8. doi: 10.1046/j.0007-1323.2001.01948.x. [PubMed: 11736980].
  • 16. Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC. Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res. 1999;84(2):138-42. doi: 10.1006/jsre.1999.5629. [PubMed: 10357910].
  • 17. Gill G; Snac Trial Group of the Royal Australasian College of Surgeons; Nhmrc Clinical Trials Centre. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol. 2009;16(2):266-75. doi: 10.1245/s10434-008-0229-z. [PubMed: 19050973].
  • 18. Lo YF, Hsueh S, Ma SY, Chen SC, Chen MF. Radioguided sentinel lymph node biopsy in early breast cancer: experience at Chang Gung Memorial Hospital. Chang Gung Med J. 2006;29(5):458-67. [PubMed: 17214389].
  • 19. McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26(32):5213-9. doi: 10.1200/JCO.2008.16.3725. [PubMed: 18838709].
  • 20. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276(22):1818-22. [PubMed: 8946902].
  • 21. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227(5):645-51. [PubMed: 9605656].
  • 22. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999;91(4):368-73. [PubMed: 10050871].
  • 23. Hill AD, Tran KN, Akhurst T, Yeung H, Yeh SD, Rosen PP, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg. 1999;229(4):528-35. [PubMed: 10203086].
  • 24. Bass SS, Lyman GH, McCann CR, Ku NN, Berman C, Durand K, et al. Lymphatic mapping and sentinel lymph node biopsy. Breast J. 1999;5(5):288-95. [PubMed: 11348304].
  • 25. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg. 1997;226(3):271-6. [PubMed: 9339933].
  • 26. Smidt ML, Janssen CM, Kuster DM, Bruggink ED, Strobbe LJ. Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance. Ann Surg Oncol. 2005;12(1):29-33. doi: 10.1007/s10434-004-1166-0. [PubMed: 15827775].
  • 27. Holwitt DM, Gillanders WE, Aft RL, Eberlein TJ, Margenthaler JA. Sentinel lymph node biopsy in patients with multicentric/multifocal breast cancer: low false-negative rate and lack of axillary recurrence. Am J Surg. 2008;196(4):562-5. doi: 10.1016/j.amjsurg.2008.06.009. [PubMed: 18760396].
  • 28. Lynch MA, Jackson J, Kim JA, Leeming RA. Optimal number of radioactive sentinel lymph nodes to remove for accurate axillary staging of breast cancer. Surgery. 2008;144(4):525-31. doi: 10.1016/j.surg.2008.06.005. [PubMed: 18847635].
  • 29. Blessing WD, Stolier AJ, Teng SC, Bolton JS, Fuhrman GM. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. Am J Surg. 2002;184(4):341-5. [PubMed: 12383897].
  • 30. Takei H, Suemasu K, Kurosumi M, Horii Y, Ninomiya J, Kamimura M, et al. Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer. Breast Cancer. 2006;13(2):179-85. [PubMed: 16755114].
  • 31. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2(6):335-9. [PubMed: 8130940].
  • 32. Christiansen P, Friis E, Balslev E, Jensen D, Moller S, Danish Breast Cancer Cooperative G. Sentinel node biopsy in breast cancer: five years experience from Denmark. Acta Oncol. 2008;47(4):561-8. doi: 10.1080/02841860802023206. [PubMed: 18465323].
  • 33. Bulte CS, van der Heiden-van der Loo M, Hennipman A. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study. Eur J Surg Oncol. 2009;35(1):25-31. doi: 10.1016/j.ejso.2008.06.001. [PubMed: 18640809].
  • 34. Poletti P, Fenaroli P, Milesi A, Paludetti A, Mangiarotti S, Virotta G, et al. Axillary recurrence in sentinel lymph node-negative breast cancer patients. Ann Oncol. 2008;19(11):1842-6. doi: 10.1093/annonc/mdn393. [PubMed: 18550574].
  • 35. Veronesi U, Galimberti V, Paganelli G, Maisonneuve P, Viale G, Orecchia R, et al. Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer. 2009;45(8):1381-8. doi: 10.1016/j.ejca.2008.11.041. [PubMed: 19128957].
  • 36. van Wely BJ, Smidt ML, de Kievit IM, Wauters CA, Strobbe LJ. False-negative sentinel lymph node biopsy. Br J Surg. 2008;95(11):1352-5. doi: 10.1002/bjs.6348. [PubMed: 18844270].
  • 37. Bergkvist L, de Boniface J, Jonsson PE, Ingvar C, Liljegren G, Frisell J, et al. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study. Ann Surg. 2008;247(1):150-6. doi: 10.1097/SLA.0b013e318153ff40. [PubMed: 18156935].
  • 38. Blanco I, Moriyon C, Santamaria L, Carrocera A, Diaz D, Lezana M, et al. [Our experience of the clinical application of sentinel node biopsy in breast cancer]. Cir Esp. 2007;82(6):352-7. [PubMed: 18053505].
  • 39. Zavagno G, Carcoforo P, Franchini Z, Renier M, Barutta L, De Salvo GL, et al. Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients. Eur J Surg Oncol. 2005;31(7):715-20. doi: 10.1016/j.ejso.2005.04.006. [PubMed: 16005176].
  • 40. Roka S, Konstantiniuk P, Heck D, Schrenk P, Jagoutz Herzlinger M, Koeberle Wuehrer R, et al. Axillary recurrence after sentinel node biopsy. Eur Surg. 2002;34(5):280-2. doi: 10.1046/j.1563-2563.2002.02068.x.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments